Ducongé, F.
53  results:
Search for persons X
?
1

Le projet DOT-IMAGER:

Ducongé, F. ; Pestourie, C. ; Tavitian, B....
IRBM.  31 (2010)  2 - p. 70-72 , 2010
 
?
2

Metastasis-specific aptamers inhibit migration of cancer ce..:

Zueva, E. ; Rubio, L. Illan ; Duconge, F..
European Journal of Cancer Supplements.  6 (2008)  9 - p. 49-50 , 2008
 
?
5

In vitro selection identifies key determinants for loop-loo..:

Ducongé, F ; Toulmé, J J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1369882.  , 1999
 
?
11

2042 CYP2C19*2 and PON1 Q192R polymorphisms are associated ..:

Suarez, Dagmar F. H. ; Botton, Mariana R. ; Scott, Stuart A....
Journal of Clinical and Translational Science.  2 (2018)  S1 - p. 8-8 , 2018
 
?
12

Clinical Relevant Polymorphisms Affecting Clopidogrel Pharm..:

Hernandez-Suarez, Dagmar F. ; Tomassini-Fernandini, Jonnalie C. ; Cuevas, Angelica...
International Journal of Environmental Research and Public Health.  15 (2018)  6 - p. 1115 , 2018
 
?
13

2220: Pharmacogenomic determinants in Caribbean Hispanics o..:

Melin, Kyle ; Duconge, Jorge ; Hernandez Suarez, Dagmar F.
Journal of Clinical and Translational Science.  1 (2017)  S1 - p. 25-25 , 2017
 
?
14

Clinical determinants of clopidogrel responsiveness in a he..:

Hernandez-Suarez, Dagmar F. ; Scott, Stuart A. ; Tomey, Matthew I....
Therapeutic Advances in Cardiovascular Disease.  11 (2017)  9 - p. 235-241 , 2017
 
?
15

Potential of a Pharmacogenetic-Guided Algorithm to Predict ..:

Hernandez-Suarez, Dagmar F. ; Claudio-Campos, Karla ; Mirabal-Arroyo, Javier E....
Journal of Investigative Medicine High Impact Case Reports.  4 (2016)  4 - p. 232470961668204 , 2016
 
1-15